health
February 26, 2026
AI Drug Discovery: How Roche Accelerates Health Innovation
Roche harnesses AI & machine learning to transform pharmaceutical research, reducing development timelines and advancing sustainable healthcare strategies
TL;DR
- Roche is using AI and machine learning to accelerate pharmaceutical research and development.
- The 'lab in a loop' system integrates AI into the drug discovery pipeline, using experimental data to generate and test predictions for drug targets.
- Partnerships with AWS and NVIDIA enhance Roche's computational power for AI model execution and data analysis.
- Roche has modernized its global laboratory supply chains by implementing Tecsys' Elite platform across over 1,000 labs.
- In Nigeria, Roche improved supply chains by moving to a direct buy-and-sell model, reducing intermediaries and costs.
- Roche's sustainability strategy focuses on equitable access to innovation, fair workplaces, environmental protection, and achieving net-zero carbon emissions by 2045.
- The company implements circular economy principles, energy efficiency, and renewable energy adoption to minimize environmental impact.
Continue reading the original article